Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-03 @ 11:31 PM
Study NCT ID:
NCT04520451
Status:
COMPLETED
Last Update Posted:
2025-10-14
First Post:
2020-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
Sponsor:
Principia Biopharma, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-15
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-11
First Submit QC Date:
None
Study First Post Date:
2020-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-10-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED